Search This Blog

Friday, December 21, 2018

The Myth of Medicare Magic


The Affordable Care Act (ACA) has been invalidated by a federal district court in Texas. The ruling will certainly be appealed and won’t take effect immediately. Even so, it may lead Congress to consider a bipartisan replacement. That will not be easy.
Some have already called for an even more expansive approach than the ACA — a mandatory, single-payer, government-run health insurance program for all Americans, often referred to as “Medicare for All.” Others will advocate a much smaller bill that bans insurance companies from discriminating against individuals with pre-existing conditions, but only if they maintain more-or-less continuous private health insurance coverage, largely at their own expense. The difficult part there is having a credible enforcement mechanism for the continuous coverage requirement. Even if someone willfully plays the “insurance lottery” and goes without insurance until they need it, most politicians and hospital administrators would have difficulty denying them needed medical care. That is the heart of our healthcare problem. No one wants to play the “bad cop” when healthcare is involved. That was the problem with the individual mandate.
Unfortunately, the same problem exists — to an even greater degree — with Medicare for All. We know that from over 50 years of experience with our current Medicare program for the elderly and studies conducted by liberal-leaning research institutes that would seem to be quite favorably inclined towards the program. The problem is not that government is too tough — imposing excessive taxes and fees or denying benefits with “death panels.” The problem is that Congress is unable to say “no” to a large and vocal portion of the population, and is also unable to impose the annual taxes or fees necessary to pay for its generosity.
If Medicare covered everyone in the society — not just the elderly — the problem of not having the political will to impose adequate taxes or fees could be much worse.
This has been illustrated with painful clarity by a highly respected liberal-leaning research institution. Scholars at the Urban Institute recently updated a study that shows just how much of a typical retiree’s Medicare benefits are actually “paid for” in payroll taxes and premiums. The results are startling, to say the least. For a very large percentage of the population, less than half of the programs costs — closer to 33% in the case of a typical worker — are actually covered by the taxes paid over a working lifetime by the worker and his or her employers.
For example, in the case of a single woman with a lifetime average income of around $51,300 in today’s dollars who retires in 2020, the total costs of her Medicare benefits are $262,000. That is what a lump-sum insurance premium would cost in 2020 to obtain Medicare benefits for the rest of her life, according to the scholars at the Urban Institute. In contrast, the Medicare taxes paid into the system on her behalf would only be worth $79,000 at that time. That includes the taxes paid by her employer and interest computed as if the taxes had been put into a tax-free “lock box” until she reached age 65. The shortfall is $183,000. Expressed differently, only 30% of her Medicare benefits were “paid for” by the taxes paid into the system during her working life, including the taxes paid by her employers and a reasonable return on the funds invested until they were needed.
The shortfall is far worse with a married couple where the single earner made an average lifetime income of $51,300 but benefits are provided for both spouses. There, the value of the taxes paid would grow to the same $79,000 at retirement, but the total cost of the couple’s lifetime Medicare benefits at that time would be a lump sum payment of $486,000. That is a shortfall of $407,000. Less than 17% of that couple’s Medicare benefits were “paid for” by their taxes — according to the Urban Institute methodology.
As income rises the situation gets better, since Medicare taxes are levied at a rate of approximately 2.9% on all wages or self-employment income. Consider a woman making the equivalent of $127,000 per year in today’s dollars before retiring in 2020. Her benefits would cost $262,000 but the value of her lifetime taxes would have grown to $188,000. The shortfall is still there, but it is only $74,000. Her taxes, including those of her employer, would have “paid for” 72% of her benefits.
Although the study does not do the math, it appears that a single man or woman making an annual wage (or self-employment income) of around $175,000 in today’s dollars would be close to breaking even – perhaps paying a little more in taxes than his or her benefits were worth. For a married couple enjoying benefits for two spouses, the earners apparently would need to be making close to $350,000 in today’s dollars to fully “pay for” their benefits through payroll taxes, including those paid by their employers and a reasonable return on the funds until they reached retirement age. Of course, those amounts are far above the average American income.
Skeptics may question the study’s methodology, but it seems quite sound. The Urban Institute scholars computed the total amount of Medicare taxes payable, both by employers and employees, for individuals at different income levels from the beginning of the program in the 1960s. They computed the “future value” of those amounts when the worker reached retirement age by assuming that the taxes were deposited by the employer and employee into a tax-free account earning a “real” return of 2% (i.e., after inflation). They then compared those accumulated amounts at age 65 — which differed depending on income levels and marital status — with an estimate of the cost of a single-premium health insurance policy providing Medicare-like benefits. As indicated, in some cases that would include spousal benefits for a non-working or lower-earning spouse.
There may well be good arguments, both moral and political, for providing what might otherwise be considered a subsidy — or a form of “income redistribution” — to these hard-working Americans when they retire after a lifetime of work. That is not the point. The point is that no one actually took a vote to decide to provide these subsidies, and the beneficiaries themselves were told, or tacitly allowed to assume, that they had “paid for” their benefits. The same, or worse, is likely to occur with Medicare for All. That is, the immediate effects of such a program may not be punitive taxes that punish the economy, or “death panels” to ration healthcare as some have warned. The effects may be a fiscal disaster when we run out of money on an even larger scale than is occurring with traditional Medicare.
In traditional Medicare, at least, there is the “fiction” that one generation is paying for another. That may have been true when Social Security or Medicare were first enacted, and one had to advance the funds, on a one-time basis, to pay for a generation that had never contributed but was being provided with benefits nonetheless. Now that we are talking about people who have been in the program their entire working lives, passing the costs to the next generation is not a solution to the ongoing and permanent failure to collect in payroll taxes — on an individual by individual basis — the present value of what is being paid out in benefits to those individuals. That is, it is not a funding or financing problem of coming up with the cash — the program is designed to be permanently insolvent — unless somehow future generations are much larger or healthier.
In contrast, by leaving most medical insurance for the non-elderly in private hands — albeit with some regulation at the edges — the Congress does not have to play the “bad cop” in setting insurance rates or deciding what procedures and drugs to cover, or not. With Medicare for All, Congress would have to make all of those hard decisions, facing the wrath of 100% of the voters, not only the elderly, if they were too restrictive. History has shown that Congress just cannot handle that kind of fiscal responsibility — particularly when healthcare expenditures are involved. While some argue that a single-payer program like Medicare is more efficient because it uses only a single bureaucracy — even if that was true — and we were saving, say, 10% of the costs by simplifying the bureaucracy — any cost savings would be beside the point if Congress ultimately lacks the political will to charge an average beneficiary more than 33% of the actual costs. If you save a little on administrative costs, but are running a shortfall of 67% for an average worker, you can’t make that up in volume.

Acorda: FDA OKs INBRIJA (levodopa inhalation powder)


  • First and Only FDA-Approved Inhaled Levodopa for Intermittent Treatment of OFF Episodes in People with Parkinson’s Taking Carbidopa/Levodopa
  • Expected to be Available by Prescription in First Quarter 2019
  • Based on Innovative ARCUS® Technology Platform for Inhaled Drug Delivery
  • Conference Call on Monday, December 24, 2018 at 8:30am Eastern Time
Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the U.S. Food and Drug Administration approved INBRIJA™ for intermittent treatment of OFF episodes in people with Parkinson’s disease treated with carbidopa/levodopa. OFF episodes, also known as OFF periods, are defined as the return of Parkinson’s symptoms that result from low levels of dopamine between doses of oral carbidopa/levodopa, the standard oral baseline Parkinson’s treatment.
“Today’s approval of INBRIJA marks a major milestone for both Acorda and the Parkinson’s community, for whom we are gratified to have developed this much needed therapy,” said Ron Cohen, M.D., Acorda President and CEO. “This milestone resulted from over two decades of research and development, beginning in the laboratory of Dr. Robert Langer at Massachusetts Institute of Technology, through years of enormous perseverance and ingenuity by the entire Acorda team.”
“Despite being on treatment, patients may experience OFF periods as Parkinson’s progresses, which can be disruptive,” said Todd Sherer, Ph.D., CEO, The Michael J. Fox Foundation. “The Foundation provided funding for the early clinical development of INBRIJA because patients told us that OFF periods were one of their most serious issues. We knew we had to help address this unmet need, and this approval is a significant step forward for the community as it provides a new option to manage these gaps in symptom control.”
“In the clinical study program, INBRIJA established its safety profile and demonstrated clinically meaningful improvements in motor function, as measured by the UPDRS Part III,” said Robert A. Hauser, M.D., MBA, Professor of Neurology and Director of the Parkinson’s Disease and Movement Disorders Center at the University of South Florida. “INBRIJA helps address a significant unmet need for people with Parkinson’s, and we look forward to adding this new treatment option to our armamentarium.”
FDA approval of INBRIJA was based on a clinical program that included approximately 900 people with Parkinson’s on a carbidopa/levodopa regimen experiencing OFF periods. INBRIJA is not to be used by patients who take or have taken a nonselective monoamine oxidase inhibitor such as phenelzine or tranylcypromine within the last two weeks.

Federal Judge Won’t Halt CVS-Aetna Integration


A federal judge on Friday said he would accept CVS Health Corp.’s offer to keep certain aspects of its newly acquired Aetna unit’s operations separate for now, stopping short of an earlier suggestion that he might order the company to halt its integration efforts.
U.S. District Judge Richard Leon in Washington, D.C., had previously voiced concerns about the companies’ settlement with Justice Department antitrust enforcers, which allowed the drugstore giant to move forward with its nearly $70 billion deal for the insurer. He must decide whether to approve the settlement.
In an order released Friday, the judge said he would accept conditions proposed by CVS, which would remain in place while he weighs whether the antitrust settlement is in the public interest. That review process could take six months or longer.
He didn’t require that an outside monitor be brought in to ensure the company lives up to its commitments.
CVS had argued that halting all integration would cause irreparable harm to the company and its customers. Instead, it offered measures it said would help facilitate Judge Leon’s review. For instance, CVS pledged that Aetna would maintain its historical control over pricing of products and services for its insurance customers, and that CVS and Aetna wouldn’t exchange competitively sensitive information for now.
A CVS spokesman declined to comment on the judge’s order.

Group Pays off $1.5M in New Yorkers’ Unpaid Medical Debt


THE medical bills of nearly 1,300 upstate New York residents have been paid off thanks to the efforts of two women working with an organization that buys medical debt bundled for pennies on the dollar.
The Times Union of Albany reports Judith Jones and Carolyn Kenyon, both of Ithaca, raised $12,500 last summer and donated it to RIP Medical Debt. The four-year-old, New York-based not-for-profit corporation buys and forgives unpaid medical debt across the U.S. for those in need.
The newspaper reports Monday that the group used the donation to pay off medical debts totaling $1.5 million for 1,284 people in upstate New York.
Jones and Kenyon are members of Finger Lakes for the New York Health Act, a chapter of Campaign for New York Health, which advocates for universal health coverage.

UnitedHealthcare, Aetna, Humana back group pushing Medicare Advantage


A group gaining influence in Washington as a champion for Medicare beneficiaries is bankrolled by major health insurance companies that are trying to cash in on private coverage offered through the federal health insurance program.
The Better Medicare Alliance claims a far-flung network of seniors, with a Facebook community of more than 380,000 and 110,000 signed up to receive email alerts. Its website displays profiles of “BMA Seniors” who describe private Medicare plans in glowing terms. The Associated Press found that one of the featured seniors, David Kievit, died in March at age 91.
The multimillion-dollar budget for the alliance isn’t supplied by seniors, but by UnitedHealthcare, Aetna and Humana, according to the group’s president and its federal tax returns. The three insurance giants together account for close to 50% of all enrollees in private “Medicare Advantage” plans and stand to benefit as that part of Medicare keeps growing.
The organization’s website and Facebook page don’t say where its money comes from, making it easy to miss the industry tie.
Since its establishment in December 2014, the alliance has built its profile. It lobbies Congress and the administration and sponsors research. It has spent $370,000 so far this year on lobbying Congress primarily, according to disclosure records. Among other issues, the alliance is seeking the repeal of a tax on health insurers imposed by the Obama-era health care law.
President and CEO Allyson Schwartz enjoys credibility among Democrats, having helped pass the Affordable Care Act as a Democratic congresswoman from Pennsylvania. And Republicans have long been fans of private Medicare plans, giving the alliance a foothold in both political parties.
David Lipschutz, a senior policy attorney for the Center for Medicare Advocacy, a nonprofit legal organization that represents Medicare beneficiaries, called the Better Medicare Alliance an “Astroturf group.” The term refers to an organization that casts itself as a grassroots movement to mask their corporate interests.
“They represent themselves as representing Medicare beneficiaries, but they really represent the interests of the insurance industry,” Lipschutz said.
Schwartz rejects any suggestion that the organization is a front for the insurance industry. She said during an interview with the AP that the alliance’s funding sources “are well known,” even though the names and addresses of donors were blacked out of copies of the alliance’s tax returns that it provided to AP.
Federal rules permit nonprofits like the Better Medicare Alliance to shield the identities of donors. Critics say that’s problematic because the public has no way of knowing whether the anonymous donors have a specific interest in a matter before the administration, Congress or the courts.
“I don’t know that this entity is representative of the people who receive this type of insurance, or is it representing the interests of the businesses that offer this type of insurance,” said Daniel Borochoff, the president of CharityWatch, a national watchdog group. He reviewed alliance tax documents for AP and said it appears to be “akin to a trade organization.”
The alliance has received $19.9 million in donations over the last three years, accounting for 99.9 % of its total revenue during that period, according to the organization’s tax returns for 2015 through 2017. Schwartz said when asked that the money came from UnitedHealthcare, Aetna and Humana.
“You can ask any nonprofit organization about their funders and say, ‘Do they tell you what to do? Does that dictate what you do?'” Schwartz said. “You pay attention to your funders, but you ought to be making your own decisions. We do.”
She said BMA has 125 “allies” that include the insurance companies, local agencies that serve seniors, patient advocacy groups, and nurse and doctor associations that all back Medicare Advantage. They include the American Medical Group Association and Meals on Wheels America.
“Our job is to find the common ground,” Schwartz said.
Medicare Advantage is a growing business for insurers. About 22 million Medicare beneficiaries, or close to 2 in 5, are expected to be covered by a Medicare Advantage plan next year. The private plans promise coordinated care and generally offer lower out-of-pocket costs. They limit choice of doctors and hospitals and employ other restrictions such as prior authorization for services.
UnitedHealthcare has 25 % of the Medicare Advantage enrollees, Humana has 17 % and Aetna has 8 %, according to an analysis of government data by the nonpartisan Kaiser Family Foundation.
Schwartz earned just over $600,000 last year in base salary, bonus pay and other compensation, an increase of $52,000 from 2016. The alliance’s board of directors determined her salary following a compensation survey of comparable nonprofits, according to the tax returns, but she makes more than the top executives who run other Medicare-related organizations.
Max Richtman, president of the National Committee to Preserve Social Security and Medicare, earned $391,185 in 2017, according to the organization’s latest tax return. The group advocates against cuts to retirement security programs.
James Firman, president of the National Council on the Aging, was paid $343,558, according to the organization’s tax return that covers the year between July 1, 2016 and June 30, 2017, the latest available. The council is a decades-old advocacy group.
Among the senior profiles on the Better Medicare Alliance’s website is one of Kievet, a World War II veteran who died in March. There’s a photo of him wearing his veteran’s cap, along with a brief first-person article.
His family was startled to see his photo there, said his son, John Kievit, who lives near Houston.
“I’d like to see the article updated, at least,” he said.

Outpatient facilities surge as industry values more convenient, affordable care


The number of outpatient centers increased 51% from 2005 to 2016, a trend that shows no sign of slowing.
The number of outpatient facilities jumped from 26,900 to 40,600 between 2005 and 2016, according to a new report from commercial real estate firm CBRE. Rents have followed. They reached a record high in the second quarter of this year, rising 1.4% year over year to $22.90 per square foot, driven by areas with low vacancy rates like Louisville, Ky., Seattle, Nashville, Manhattan and Indianapolis.
It mainly comes down to two things: making services more convenient and more affordable, said Christopher Bodnar, vice chairman of CBRE Healthcare Capital Markets.
“That strategy moves along the entire continuum of care for providers. It’s front and center for their real estate strategy as well,” Bodnar said, although there will always be demand for acute beds, he added. “We are seeing health systems look to decompress their main campus and look to move more services to an outpatient setting.”
The report represents healthcare’s transition from vast acute-care footprints to more convenient outpatient space. Some health systems have moved their clinics and ambulatory facilities off their main campus to make way for more beds and specialty care. But a significant number of providers have already pared down their acute operations to build outpatient networks closer to where people live and shop, responding to consumers who demand more accessible, affordable care as they shoulder more out-of-pocket costs.
Health systems are looking to keep pace with mergers like CVS Health and Aetnaand Optum’s continued push into the market, both of which draw patients away from the hospital into a retail setting. Many major health systems continue to watch their inpatient admissions dwindle and their outpatient visits grow.
Reimbursement pressure is also pushing providers to lower-cost settings that could offer higher margins, said Mark Lamp, executive managing director of healthcare at CBRE.
“Technology is also changing so fast that providers can bring care to the consumer quicker and in a different way,” he said. “Providers recognize that they need to deliver care differently than they have in the past.”
They need adaptable real estate that can evolve with technology, Lamp added.
Healthcare is projected to account for nearly a third of the job growth from 2016 to 2026, according to the Bureau of Labor and Statistics.
Outpatient center employment has more than doubled since 2003. It grew 3.5% year over year in October 2018 compared with 2% annual growth in overall healthcare employment, CBRE’s analysis of BLS data show. Ambulatory jobs are up 77% since 2000.
GoHealth Urgent Care will open its 116th location this week, growing from just five spaces in around four years. GoHealth and its affiliate Dignity Health just completed the acquisition of the six urgent-care centers operated by the Bay Area’s Golden Gate Urgent Care.
“I’ve watched the growth and development of ancillary sites in healthcare for the last decade and a half,” said Todd Latz, CEO of GoHealth. “The numbers we are seeing in terms of their proliferation represents a trend that is accelerating.”
Partnering with a health system facilitates same-day referrals and cuts down on duplicative or misguided care as healthcare data are disseminated in real time, Latz said. More of these types of partnerships will continue, he said.
“Clinicians can get to the heart of the matter much more quickly because of the connectivity to a health system and the integrated approach to care,” Latz said. “We are one piece of a much larger movement.”
Consolidation, in many cases, has bolstered balance sheets. Combined institutions have deeper pockets to pull from and can invest in these types of partnerships and mergers and acquisitions that expand their ambulatory network.
Medical office transaction volume decreased to just less than $12 billion in the second quarter but didn’t stray far from the cyclical high of $14.2 billion, according to CBRE.
These deals are drawing interest from state pension funds and other institutional investors, Bodnar said. They are shying away from multifamily and retail investments that may have peaked, he said.
“Healthcare provides more of a runway to withstand a correction in the market,” Bodnar said. “People will always need care.”
Medical office vacancy rates have consistently been lower than the total office sector, according to CBRE data. It dipped from 11.1% in 2010 to 8.4% in the second quarter of 2018.
More medical office deals are being made in cities with high population growth, CBRE data show. Cities like Phoenix, Houston, Dallas/Fort Worth and Atlanta are among the top markets for total transactions completed over the past year. Houston, Minneapolis, St. Paul, Atlanta, Chicago, California’s Inland Empire, Kansas City and Boston rank among the top markets for square footage under construction.
Big employers in these markets are looking to curb their coverage costs as they carve out narrow networks. These often incentivize employees to seek care in lower-cost settings outside of the hospital. Technology-enabled ambulatory space can facilitate collaboration among providers, a key to healthcare’s new direction.
“Managing that population and planning for that growth has been top of mind for health systems in markets where there are huge increases in population,” Lamp said.
Still, medical office construction levels have begun to trail off after increasing 60% from 2011 to 2017.
One thing that could further stall investment, at least on the health system side, is the proposal to level pay for outpatient services regardless of where they were delivered. The CMS issued a site-neutral payment proposal that would eliminate the rate discrepancy for hospital-owned outpatient departments and those owned by physicians. Higher reimbursement rates for hospital-owned facilities were initially intended to offset costs related to maintaining around-the-clock emergency services and specialized equipment, although new technology has somewhat leveled the playing field.
The current payment model has led to health systems building more outpatient facilities, said Paul Ginsburg, director of the USC-Brookings Schaeffer Initiative for Health Policy and the Leonard D. Schaeffer chair of health policy studies at the Brookings Institution.
“Under site-neutral payment, less of the new capacity would be health-system owned,” he said.
Hospitals have begun to slow their development activity as they re-examine their operations and adapt their real estate strategies, real estate experts said.
But as they rethink their real estate strategy, health systems are forming more partnerships and joint ventures with real estate management firms to redeploy capital and hand off the maintenance and upkeep of their facilities to a professional.
“It allows them to free up capital, still have some equity and control of their real estate with a partner whose sole focus is to own and operate buildings in the most efficient manner,” Bodnar said.
As providers snatch up more medical office space, it’s important they pay close attention to rental rate commitments, he said. The right control provisions can prevent significant rent increases after a lease expires.
“This is a new environment of demand for these types of facilities,” Bodnar said.

Death rates for heart failure, pneumonia rise as readmissions targeted


Another study has found a rise in mortality for patients with certain conditions as hospitals are encouraged to lower 30-day readmissions through CMS’ penalty program.
The new study, released Friday in JAMA, found death rates rose slightly among heart failure and pneumonia patients as hospitals were motivated to reduce 30-day readmission rates under the CMS’ Hospital Readmissions Reduction Program, or HRRP. This is the second study that has been published finding a correlation between the readmissions penalty program and a rise in death among patients with conditions the program targets.
The most recent study compared mortality rates for hospitalizations for heart failure, heart attack and pneumonia from before the readmissions program began to a few years after the program’s implementation. The authors found death rates for heart failure patients rose by 0.52% after the readmissions program was implemented compared to a 0.27% rise in mortality in the few years before the program. Furthermore, mortality rates from pneumonia were stable before the readmissions program went into effect with a 0.04% increase from 2005 to 2010 but rose by 0.44% from 2012 to 2015, after the program began.
Dr. Rishi Wadhera, lead author of the study and an investigator in the Smith Center for Outcomes Research in Cardiology at Beth Israel Deaconess Medical Center, said that although it’s difficult to know if the rises in mortality were directly related to the readmissions program, the findings alone are enough for the CMS to re-evaluate it.
“It’s really hard to know whether the policy is directly responsible for the acceleration in mortality, but in the face of uncertainty I think we should err on the side of caution,” he said.
Dr. Robert Yeh, co-author of the study and director of the Smith Center for Outcomes Research, said he doesn’t think the readmissions program should be expanded “until we have a better understanding of why these trends are occurring.”
A study released last November also published in JAMA found mortality rose among Medicare beneficiaries with heart failure after implementation of the readmissions program. That study eventually led to a report by the Medicare Payment Advisory Commission, which concluded there was “no compelling evidence to suggest that the readmission reduction policy has had a negative effect on mortality. To the extent that there is a small effect, our data as a whole suggest the HRRP may have done more to improve than harm mortality rates.”
CMS Chief Medical Officer Dr. Kate Goodrich said in a statement that the Medicare Payment Advisory Commission studied the same data and didn’t find an indication of higher mortality for heart failure patients.
“CMS monitors the impact of our programs, including looking at the input from peer-reviewed research and other sources, as we work to improve health outcomes while ensuring Americans are receiving safe, quality healthcare,” she said.
The readmissions program currently includes six conditions: heart attack, pneumonia, chronic obstructive pulmonary disease, hip and knee replacements and coronary artery bypass graft surgery.
Wadhera and Yeh choose to evaluate heart attack, heart failure and pneumonia because those are the initial three conditions the program started with in 2012.
The study didn’t find heart attack patients experienced rises in mortality compared to before the program was implemented and after. Yeh said that may be because heart attack is a single acute event that can be treated with less likelihood for complications that lead to readmissions. Heart failure is a chronic condition that is harder to treat whereas pneumonia is usually diagnosed in frail, sickly and older adults.
Since the JAMA study last year, quality experts raised concerns that hospitals may be denying patients necessary admissions in order to avoid a readmission penalty, which is up to 3% of their Medicare payments.